May 1st, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...
Read MoreJournal des Entreprises – Coronavirus – XENOTHERA : « Nous prenons des risques entrepreneuriaux...
Read More
[Article presse ] Par Frédéric Thual- La Tribune , à Nantes | 26/03/2020, 15:08 Avec...
Read More
[Article Presse] Par Emmanuel Guimard Publié le 20 mars 2020 à 17h14...
Read More
[Communiqué ] Nantes , le 19 mars 2020 XENOTHERA pense détenir aujourd’hui...
Read More
[ Communiqué ] Nantes, December 12th, 2019 XENOTHERA is pleased to give...
Read More
Nantes, September 11th, 2019 – XENOTHERA announces it has received Czech Republic regulatory...
Read More
XENOTHERA will participate at ESOT 2019 that will take place...
Read More
Nantes, June 21st, 2019 – XENOTHERA announces receivability after its submission of a Clinical...
Read MoreKidney graft recipients receiving anti-lymphocyte globulins of animal origin undergo unwanted immune...
Read More
XENOTHERA has started to gather investors for a Series A round of...
Read More
Nantes, november 2017 The fresco, more than 8 meters long, has been...
Read More
Nantes, September 2017 We have been selected for the 2017 entrepreneur awards...
Read More
August 25th, 2016 XENOTHERA, a young start-up from Nantes, is honored to...
Read More
June 10th, 2016 XENOTHERA, a young biotech who develops an innovative immunosuppressant,...
Read More
September 1st, 2015 The Medicine Faculty of Nantes is welcoming the start-up...
Read More
July 24th, 2015 Several partners of XENOTHERA will be present at the...
Read More
July 23th, 2015 XENOTHERA will participate in the Biopharm America that will...
Read More